Boston Scientific Corp. (BSX) concluded trading on Wednesday at a closing price of $66.99, with 4.74 million shares of worth about $317.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.54% during that period and on on Wednesday the price saw a gain of about 0.84%. Currently the company’s common shares owned by public are about 1.47B shares, out of which, 1.46B shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 84 times over the past 12 months. They bought 724,713 shares in 48 of the transactions. In 36 selling transactions, insiders dumped 1,135,824 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 67.00, or with a gain of 0.84%. Stock saw a price change of 1.89% in past 5 days and over the past one month there was a price change of 9.26%. Year-to-date (YTD), BSX shares are showing a performance of 15.88% which increased to 43.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $46.20 but also hit the highest price of $67.32 during that period. The average intraday trading volume for Boston Scientific Corp. shares is 6.44 million. The stock is currently trading 2.63% above its 20-day simple moving average (SMA20), while that difference is up 9.54% for SMA50 and it goes to 22.34% higher than SMA200.
Boston Scientific Corp. (NYSE: BSX) currently have 1.47B outstanding shares and institutions hold larger chunk of about 94.17% of that.
The stock has a current market capitalization of $98.28B and its 3Y-monthly beta is at 0.78. PE ratio of stock for trailing 12 months is 62.59, while it has posted earnings per share of $1.07 in the same period. Its PEG reads 5.20 and has Quick Ratio of 0.82 while making debt-to-equity ratio of 0.49. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BSX, volatility over the week remained 1.14% while standing at 1.37% over the month.
Analysts are in expectations that Boston Scientific Corp. (BSX) stock would likely to be making an EPS of $0.51 in the current quarter, while forecast for next quarter EPS is $0.56 and it is $2.55 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.5 which is $0.52 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.47 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 10.04% while it is estimated to increase by 13.18% in next year. EPS is likely to grow at an annualized rate of 12.04% for next 5-years, compared to annual growth of -2.05% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on February 01, 2024 offering a Buy rating for the stock and assigned a target price range of between $65 and $80 to it. Coverage by Robert W. Baird stated Boston Scientific Corp. (BSX) stock as an Outperform in their note to investors on July 19, 2023, suggesting a price target of $59 for the stock. On June 30, 2023, CL King Initiated their recommendations, while on May 30, 2023, Morgan Stanley Resumed their ratings for the stock with a price target of $58. Stock get a Buy rating from UBS on March 29, 2023.
